Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].

Bulletin du cancer - 1 Dec 2013

Gonçalves Anthony, Moretta Jessica, Eisinger François, Bertucci François

Abstract excerpt

Breast cancer is now considered as a large collection of distinct biological entities, the management of which is increasingly personalized. Personalized medicine - defined as a medicine, which uses molecular profiles, notably genetic profiles, from patients and/or tumors to tailor therapeutic decisions - is now introduced in the management of breast cancer at any stages: screening and prevention of hereditary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genomics

Share to Neoplasm Staging

Share to Neoplastic Cells, Circulating

Share to Precision Medicine

Source

Identifiers

PMID: 24225763
DOI: 10.1684/bdc.2013.1856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].PMID 24225763Read ↗

Personalized medicine: present and future of breast cancer management.Semantic proximity Read ↗

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

Hereditary Breast and ovarian cancer: providing personalized medicine.Semantic proximity Read ↗

[Genomic basis for breast cancer: advances in personalized medicine].Semantic proximity Read ↗

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.Semantic proximity Read ↗

Genetics and Genomics of Breast Cancer: update and translational perspectives.Semantic proximity Read ↗

Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Semantic proximity Read ↗

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity Read ↗

Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug Resistance.Semantic proximity Read ↗

Genomic analysis: toward a new approach in breast cancer management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.